Vaccination Against Herpes Zoster in Patients With Inflammatory Rheumatic Diseases

NCT06763783 · clinicaltrials.gov ↗

PHASE4

Phase

ENROLLING_BY_INVITATION

Status

240

Enrollment

OTHER

Sponsor class

Conditions

Systemic Vasculitis
Spondylarthropathies
Psoriatic Arthritis
Scleroderma
Polymyalgia Rheumatica (PMR)
Juvenile Chronic Arthritis
Polyarthritis
SLE
Giant Cell Arteritis (GCA)

Interventions

DRUG: Shingrix
DRUG: vaccination with 2 doses of Shingrix vaccine

Sponsor

Region Skane

Collaborators

[object Object]